#Open journalism No news is bad news

Your contributions will help us continue to deliver the stories that are important to you

Support The Journal
Dublin: 8°C Saturday 15 May 2021
Advertisement

EU drug watchdog reviewing possible blood clot links with Johnson & Johnson Covid vaccine

It comes amid reports of four blood clot cases, one of them fatal.

Image: SIPA USA/PA Images

THE EUROPEAN UNION’S drug regulator said today it has launched a review of possible links between the Johnson & Johnson coronavirus vaccine and blood clots after reports of four cases, one of them fatal. 

The European Medicines Agency (EMA) said its safety committee “has started a review of a safety signal to assess reports of thromboembolic events” with people who had received the shot. 

“Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with Covid-19 Vaccine Janssen,” the EMA said, referring to US pharma giant J&J’s European subsidiary. 

One case occurred in a clinical trial and three cases occurred during the vaccine rollout in the USA. One of them was fatal.

The watchdog has approved the Johnson & Johnson vaccine for use but its rollout across the 27-nation EU is not due to start until later this month. 

The probe comes days after the Amsterdam-based watchdog said it was listing the same type of blood clots as a very rare side effect of the rival AstraZeneca vaccine. Both jabs use similar adenovirus vector technology.

© – AFP, 2020 

#Open journalism No news is bad news Support The Journal

Your contributions will help us continue to deliver the stories that are important to you

Support us now

About the author:

AFP

Read next:

COMMENTS (32)

This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
write a comment

    Leave a commentcancel